PTR-01

DRUG3 trials

Sponsors

Phoenix Tissue Repair, Inc.

Conditions

Recessive Dystrophic Epidermolysis Bullosa

Phase 1

A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

CompletedNCT03752905

Phoenix Tissue Repair, Inc.Recessive Dystrophic Epidermolysis Bullosa

Start: 2019-01-09End: 2020-11-30Updated: 2021-03-09

Phase 2

A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa

CompletedNCT04599881

Phoenix Tissue Repair, Inc.Recessive Dystrophic Epidermolysis Bullosa

Start: 2020-10-15End: 2021-09-01Updated: 2021-09-16

Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)

CompletedNCT05143190

Phoenix Tissue Repair, Inc.Recessive Dystrophic Epidermolysis Bullosa

Start: 2021-12-02End: 2022-08-09Updated: 2022-11-21